Ballentine Partners, LLC Insulet Corp Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Insulet Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 1,559 shares of PODD stock, worth $405,527. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,559
Previous 1,532
1.76%
Holding current value
$405,527
Previous $309,000
17.15%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PODD
# of Institutions
685Shares Held
62.7MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.2 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.02 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.58 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$758 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$592 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...